Richard Fair owns 0.00% of Enliven Therapeutics
0 shares as of the December 11, 2025 filing.
ELVN · $2.7B market capGet an email when Richard Fair’s stake moves.
Free.
The stake
0.00%
of the common shares
Stake rank
—
by dollar value of the stake
Last sale
None
no sales since 2016
Last buy
None
no purchases since 2016
Richard Fair owns 0.00% of Enliven Therapeutics, Inc.: 0 of 73,270,761 shares, worth about $0 at the 2026-10-16 close. The stake has moved from 0.00% in 2025 to 0.00% on 2026-07-28.